CompaniesGlycoVaxyn

GlycoVaxyn

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

234

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
Today
NCT02289794
Hover over trial bars to see details

Recent Trials

NCT02289794Lead Sponsor
Vaccine Against Escherichia Coli Infection
PHASE1Completed
194 participants
Started: Jan 31, 2014 · Completed: Sep 30, 2015
NCT01069471Lead Sponsor
Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella
PHASE1Completed
40 participants
Started: Feb 28, 2010 · Completed: Oct 31, 2010
Related Companies
Gsk
acquired